1. 719 CD122-directed interleukin-2 complexes and αPD-L1 differentially require innate and adaptive immunity to treat local and metastatic bladder cancer. (10th December 2020) Authors: Reyes, Ryan; Deng, Yilun; Zhang, Deyi; Ji, Niannian; Mukherjee, Neelam; Wheeler, Karen; Gupta, Harshita; Kancharla, Aravind; Garcia, Myrna; Kornepati, Anand; Svatek, Robert; Curiel, Tyler Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 719 CD122-directed interleukin-2 complexes and αPD-L1 differentially require innate and adaptive immunity to treat local and metastatic bladder cancer. (9th November 2020) Authors: Reyes, Ryan; Deng, Yilun; Zhang, Deyi; Ji, Niannian; Mukherjee, Neelam; Wheeler, Karen; Gupta, Harshita; Kancharla, Aravind; Garcia, Myrna; Kornepati, Anand; Svatek, Robert; Curiel, Tyler Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 690 CD122-selective IL-2 complexes treat ovarian carcinomas, induce Treg fragility and promote T cell stem cells. (9th November 2020) Authors: Deng, Yilun; Drerup, Justin; Zhang, Xinyue; Reyes, Ryan; Mendez, Jenny; Kancharla, Aravind; Garcia, Myrna; Bai, Haiyan; Padron, Alvaro; Gupta, Harshita; Curiel, Tyler Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 786 Distinct efficacy and immunological responses to aPD-1, aPD-L1 and aPD-L2 immunotherapy in B16 melanoma in aged versus young hosts includes T-cell stem cell effects and PD-L2 expression differences. (9th November 2020) Authors: Garcia, Myrna; Padron, Alvaro; Deng, Yilun; Kancharla, Aravind; Reyes, Ryan; Gupta, Harshita; Curiel, Tyler Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A834 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Current status of therapy for chronic myeloid leukemia: a review of drug development. (June 2008) Authors: Padmanabhan, Swami; Ravella, Saritha; Curiel, Tyler; Giles, Francis Journal: Future oncology Issue: Volume 4:Number 3(2008) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 421 Specific cephalosporin antibiotics deplete tumor PD-L1 to inhibit DNA damage sensing and sensitize to Chk1 inhibitors in vivo. (April 2022) Authors: Murray, Clare; Kornepati, Anand; Padron, Alvaro; Deng, Yilun; Garcia, Myrna; Bai, Haiyan; Curiel, Tyler Journal: Journal of clinical and translational science Issue: Volume 6(2022)Supplement 1 Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 4579 Distinct clinical and immunological responses to αPD-1, kαPD-L1 and αPD-L2 immunotherapy in B16 melanoma in aged versus young hosts includes T-cell stem cell effects and PD-L2 expression differences. Issue Volume 4:Issue(2020)Supplement 1 (June 2020) Authors: Garcia, Myrna G; Padron, Alvaro; Deng, Yilun; Gupta, Harshita; Kancharla, Aravind; Reyes, Ryan; Curiel, Tyler Journal: Journal of clinical and translational science Issue: Volume 4:Issue(2020)Supplement 1 Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗